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Although we know that certain types of childhood cancers are increasing, we do not know why.
With few exceptions, we know little about the role of environmental carcinogens in childhood
cancer. Generally, we have adequate information to screen chemicals for potential hazard for only
certain categories of chemicals-drugs, food additives, and pesticides. The U.S. Environmental
Protection Agency (U.S. EPA) is implementing the 1996 Food Quality Protection Act, which
provides added protections against pesticide risks, especially for children. But the situation is
quite different for many industrial chemicals. We lack even basic toxicity data for a majority of the
U.S. EPA's list of approximately 3000 nonpolymeric high-production-volume industrial chemicals
being produced in the United States each year that are found in consumer products and the
workplace. We know even less about the remaining 70,000 chemicals on the U.S. EPA inventory.
The U.S. EPA has initiatives underway to address the risks posed by some of these commercial
chemicals, including efforts to reduce risks posed by indoor air pollutants and household
products. These initiatives specifically address children's risks. We are supporting toxicity
screening of high-volume industrial chemicals on a cooperative international basis through the
Organisation for Economic Co-operation and Development. Until more information is available, it
is difficult to assess the possible role of these chemicals in childhood cancer and to take steps
to reduce exposure to children. Environ Health Perspect 106(Suppl 3):875-880 (1998).
http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-3/875-880goldman/abstract.html
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Introduction
The U.S. Environmental Protection Agency
(U.S. EPA) Office of Children's Health
Protection held a conference in September
on Preventable Causes of Cancer in
Children. The conference helped us to eval-
uate our knowledge about and efforts in
preventing environmentally related cancers
in children and to determine the future
directions ofour additional efforts.
We know little about how chemicals in
the environment relate to risks of child-
hood cancer. We do know that certain
types of childhood cancers are increasing,
but we do not know why. In general, the
amount and quality ofthe information on
carcinogenic and other risks depend on
the chemicals being discussed. Generally,
we have adequate data to screen chemicals
for potential carcinogenic and other haz-
ards for drugs, food additives, and pesti-
cides. Although it is often necessary to
obtain additional data for assessing chil-
dren's risks to these chemicals, we have lit-
tle information about other chemicals
regulated under the Toxic Substances
Control Act (TSCA) (1) and the Consumer
Product Safety Commission's Hazardous
Substances Act (2).
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Addressing Children's
Susceptibilities
We have even less information on infants'
and children's unique exposures and sus-
ceptibilities to chemicals, including car-
cinogens. Infants and children can be more
vulnerable to some chemicals because of
their unique exposures and susceptibilities,
but so far, our testing and research have
done little to answer questions that these
key differences raise: What is the exposure
to a chemical for the first year oflife? What
are the exposures to a toddler? What is the
total cumulative lifetime exposure? And
what health effects occur or could be
attributed to exposures at each stage? What
are the health effects for the integrated life-
time exposures? And how do children's
exposures to chemicals differ from adults'
as the result oftheir unique behavior pat-
terns? We have only partial answers to
these questions, and there is clearly a need
for more information and research to
ensure that we are providing children with
a full measure ofprotection.
We have more knowledge of carcino-
genic and other health effects ofchemicals
on fetuses, infants, and children for drugs
than for any other class ofchemicals, and it
is to this body ofknowledge that environ-
mental regulators have looked to help
screen similar environmental chemicals for
potential carcinogenic and other toxic
effects. An example of a carcinogenic drug
that may be similar to other environmental
chemicals that mimic hormones is diethyl-
stibestrol (DES), a strong estrogenic drug
taken by thousands of women to avoid
miscarriages. DES produced developmen-
tal changes in some of the fetuses that
resulted in an unexpectedly large number
ofcervical and vaginal cancers in the adult
daughters (3,4).
A 1992 compilation ofresearch on how
children differ from adults in their expo-
sure and susceptibility to chemicals con-
cluded that in some cases there may be no
difference in the response of adults and
children. In other cases, different physio-
logical and metabolic factors, pharmacoki-
netics, and diet, behavior patterns, and
other influences can make children either
more or less susceptible to the effects of
chemicals than adults (5).
For years, in setting tolerances for pesti-
cides, the U.S. EPA had been adding an
additional 10-fold uncertainty factor when
toxicity tests showed fetal developmental
effects, and we have taken into account
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Table 1. Pesticidal chemicals classified as known, probable, orpossible human carcinogens (includes both active and inert ingredients).a
Cancer class n Pesticides Regulatory status
Group A-Human carcinogens 5 Benzene, inorganic arsenic, chromium VI, coal tar, All uses canceled except
L
Group Bl-Probable with
limited human evidence
Group B2-Probable
Group C-Possible
human carcinogen
Not applicable
Classifications under proposed
revised guidelines
Likely
Known/likely
Likely/high
Exposure only
ethylene oxideb
4 Acrylonitrile, creosote, formaldehyde, cadmium
64 Acetaldehyde, acetochlor, acifluorofen (Na), aldrin, amitrole,
aniline, aramite, azobenzene, bis(chloroethyl)ether,
cacodylic acid, captafol, captan, carbon tetrachloride,
chlordane, chlordimeform, chloroaniline, chloroform,
chlorothalanil, cyproconazole, daminozide, DBCP, DDT,
1,2-dibromoethane, 1,2-dichloroethane, dichloromethane,
1,3-dichloropropene, dieldrin, di(2-ethylhexyl( phthalate,
epichlorohydrin, ethylene thiourea, fenoxycarb, folpet,
furmecyclox, haloxyfop-methyl, heptachlor, heptachlor epoxide,
hexachlorobenzene, hexachlorocyclohexane (tech), iprodione,
lactofen, lindane, mancozeb, maneb, metam sodium,
MGK 326, mirex, orthophenylphenol, oxythioquinox,
pentachlorophenol, perchloroethylene, polychlorinated biphenyls,
procymidone, )-propiolactone, pronamide, propargite, propoxur,
propylene oxide, terrazole, thiodicarb, toxaphene,trichloroethylene,
triphenyltin hydroxide, 2,4,6-trichlorophenol, UDMH
80 Acrolein, amitraz, asulam, atrazine, benomyl, bifenthrin,
bromacil, bromoxynil, calcium cyanamide, carbaryl,
clofentezine, cyanazine, cypermethrin, dacthal, dichlobenil,
diclofop-methyl, dichlorvos, dicofol, difenoconazole,
dimethenamid, dimethipin, dimethoate, dinoseb, ethalfluralin,
ethofenprox, fenbuconazole, fipronil, fluometuron, fomesafen,
hexachloroethane, hexaconazole, hexythiazox, hydramethyinon,
hydrogen cyanamide, imazalil, isophorone, isoxaben, linuron,
MBC, 2-mercaptobenzothiazole, methidathion, 3-methylphenol,
metolachlor, MGK-264, molinate, MON 21200, nitrofen,
norflurazon, oryzalin, oxadiazon, oxadixyl, oxyfluorfen,
paradichlorobenzene, parathion, pendimethalin,
pentachloronitrobenzene, permethrin, phosmet, phosphamidon,
piperonyl butoxide, prochloraz, prodiamine, propazine, propiconazole,
pyrithiobac-sodium, simazine, TCMB,tebuconazole, terbutryn,
1,1,2,2-tetrachloroethane, triadimefon, triadimenol, triallate,
tribenuron methyl, 1,1,2-trichloroethane, tridiphane, trifluralin,
triflusulfuron methyl, uniconazole, vinclozolin
4 Aliette, melamine, Rhodamine B
3 Ethoprop, isoxaflutole, propachlor
1 Diuron
3 Alachlor, benoxacor, tribufos
coal tarand chromium as
wood preservative and EtO
as a fumigant
All uses canceled except
creosote aswood preservative and
formaldehyde
All or most uses canceled or never
approved for28; others havevarious
food and other uses. All food uses to
be reassessed by 1999(some sooner)
All or most uses canceled or never
approved for 15; others havevarious
food and other uses. All food uses to
be reassessed by2006 (manysooner)
Reassess by 1999
Reassess by2002
Reassess by 1999
Abbreviations: DBCP, 1,2-dibromo-3-chloropropane; DDT, dichloro diphenyl trichloroethane; EtO, ethylene oxide; MBC, methyl 2-benzimidazolecarbamate; MGK-264, N-octyl
bicycloheptene dicarboximide; MGK 326, dipropyl isocinchomeronate; MON 21200, 4-pyridazinecarboxylic acid, 2-(4-chlorophenyl)-3-ethyl-2,5-dihydro-5-oxo-, potassium salt;
TCMTB, 2-(thiocyanomethylthio)benzothiazole; UDMH, 1,1-dimethylhydrazine (unsymmetrical dimethylhydrazine), "as impurity only; no longer cleared as inert." 'Note that all
group A's and group Bl's as well as 31 group B2's and 6 group C's were classified by entities other than the U.S. EPA Office of Pesticide Programs, i.e., U.S. EPA Office of
Research and Development, the National Toxicology Program, and/orthe International Agencyfor Research on Cancer(IARC). Because the evaluation of many ofthese chemi-
cals is an ongoing process, the information on this list may change, i.e., classifications may change. Furtherdetails are given at www.epa.gov/pesticidesbEthylene oxide was
classified as Group bythe IARC and Group B1 bythe U.S. EPA Office of Health Effects Assessment.
estimates on children's greater consump-
tion ofcertain foods, e.g., apples, peanuts,
and some grains, among others. But the
National Academy of Sciences (NAS)
National Research Council's (NRC) 1993
landmark report Pesticides in the Diets of
Infants and Children reviewed the scien-
tific literature and concluded that chil-
dren can be more susceptible not only to
some ofthe carcinogenic hazards posed by
some chemicals, but also to noncarcino-
genic risks as well, and that we needed to
give them even greater protection from
pesticides (6).
Protection ofchildren has been a priority
at the U.S. EPA since the beginning ofthe
first Clinton Administration. Risk assess-
ments now must account for children's
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special susceptibilities and exposures. Last
year U.S. EPAAdministrator Carol Browner
announced the agency's National Agenda to
Protect Children's Health, mandating that
the U.S. EPA major existing health stan-
dards be reviewed and new standards be set
that ensure the protection ofchildren (7).
The new Food Quality Protection Act
(FQPA) (8) added protections for all ages,
but specifically requires that pesticides be
safe for children. Last spring, President
Clinton issued a historic executive order that
expands the U.S. EPA's efforts government-
wide: Executive Order 13045, "Protection of
Children from Environmental Health Risks
and Safety Risks" (9). The order requires
every federal agency to make protection of
children a consideration. For the first time,
federal agencies will be required to ensure
that every standard takes into account spe-
cial risks to children. An interagency task
force led by the U.S. EPA Administrator
and Health and Human Services Secretary
will coordinate priorities for research
on children.
Carcinogenicity Testing of
Pesticides and Chemicals
The U.S. EPA's pesticide program and
other national and international bodies have
classified approximately 165 pesticidal
chemicals as "known," "probable," or "pos-
sible" human carcinogens (Table 1) (10). As
shown in Table 1, the U.S. EPA has already
taken action to ban or restrict the use ofa
number ofthesecompounds. It is important
to note that a pesticide's classification, or
hazard, is only part ofthe risk equation. We
must also consider the likely exposure to the
pesticide. Wewill reassess all these pesticides
under the FQPA, and those judged to be
probable human carcinogens or possible
human carcinogens with quantifiable risks
will be in the first group reviewed (8). As
overwhelming as this is, for the majority of
the approximately 3000 high-production-
volume industrial chemicals produced in the
United States in 1996, we have little or no
publicly available hazard screening data
(11). These chemicals, nonpolymers pro-
duced in quantities of more than 1 million
pounds per year, are found in theworkplace
and in thousands of consumer products.
Even fewer data are available for the remain-
der of the some 70,000 chemicals on the
U.S. EPAinventory.
1996 Food Quality
Protection Act
A new era ofprotection from carcinogenic
risks has arrived for children, and one of
the major driving forces is the 1996 FQPA
(8). Under the new food quality law, all
tolerances must meet a "reasonable cer-
tainty ofno harm" standard. To make this
finding, the U.S. EPA now must take into
account the aggregate impact ofall non-
worker-related sources and pathways of
exposure to a pesticide, i.e., to the com-
bined exposure to a pesticide through all
dietary routes, including drinking water, as
well as exposures resulting from use in
households and on lawns. We must also
consider cumulative effects ofa pesticide
and other substances that share common
mechanisms oftoxicity.
We now must add an additional 10-fold
safety factor to account for prenatal or post-
natal developmental toxicity. The U.S. EPA
also must consider all available information
on in utero effects. For threshold effects,
risks generally must fall below one in a mil-
lion (10-6). For nonthreshold effects, the
U.S. EPA adds a 100-fold uncertainty factor
where prenatal/postnatal toxicity and expo-
sure data for children are such that the risks
for children have not been well defined and
may be greater than the risks for adults. The
U.S. EPAmaymake a finding, based on reli-
able data, that a smaller uncertainty factor is
protective. This situation arises either when
hazards for children are well enough charac-
terized that the U.S. EPAconduded that the
pesticide is not more hazardous for children
than foradults orwhen the risks for children
are well understood and constitute the basis
for the U.S. EPA's risk assessment. The
agency also must screen for and take into
account chemicals that mimic hormones,
so-called endocrine disrupters, some of
which are known to be probable or possible
human carcinogens.
These were keysteps the NAS said were
needed to protect infants and children
from carcinogenic and other risks posed by
pesticides. For the past year, the U.S. EPA
has been working with the scientific
community to conduct new research and
to establish new testing and risk assess-
ment methods to take these factors into
account. All the requirements took effect
with the law's enactment in August 1996,
so the U.S. EPA is using its best scientific
judgment in making decisions as the new
data and risk assessment methods are
being developed.
For the past year, with guidance from
its Science Advisory Panel (SAP), the U.S.
EPA has been learning how to conduct risk
assessments taking into account the new
requirements. The SAP was established
under the Federal Advisory Committees
Act to review all U.S. EPA scientific work
under the new food qualitylaw.
The SAP has reviewed and approved
our approach to assessing cumulative risks
ofpesticides that act via a common mecha-
nism of toxicity. The International Life
Sciences Institute is helping the U.S. EPA
to identify organophosphate chemicals hav-
ing common mechanisms oftoxicity. We
are also gathering this information on car-
bamate pesticides. We hope this year, work-
ing with our stakeholders, to establish a
process to evaluate the risks from cumula-
tive exposures to the organophosphate pes-
ticides. In any case where we currently have
reliable evidence that pesticides share com-
mon mechanisms of toxicity, we will per-
form a cumulative risk assessment and
make a decision based on the results. This
will be a powerful tool in avoiding pre-
ventable risks, including cancer risks.
Perinatal Testing for
Carcinogenesis
Over the years there has been much
concern about whether current cancer test-
ing guidelines (12) adequately assess risks
for children. These were highlighted by the
NAS report, and even before the passage of
the new food quality law the U.S. EPA had
updated and improved guidelines forprena-
tal developmental and reproductive toxicity
data. Last fall, both the SAP and the U.S.
EPA Science Advisory Board approved the
newguidelines.
In addition, concerns have been
expressed that conventional cancer bioas-
says do not adequately address childhood
cancer risks. Cancer bioassays generally
begin dosing animals at 2 weeks of age
and at weaning. In 1993 the NAS report
concluded that
Estimates ofcancer risk should take into
account both the higher exposures of
infants and children to certain pesticides
and the earlier age at which these expo-
sures occur in comparison to adults.
These factors can be taken into account
using cancer risk estimation methods
that allow for time-dependent exposure
patterns and toxicological testing para-
digms that include early exposure. (6)
U.S. EPA reviewed the scientific litera-
ture to determine whether prenatal testing
should be required for assessment of car-
cinogenicity ofpesticides and concluded
that the need for perinatal carcinogenesis
tests should be determined on a case-
by-case basis. This follows a similar deci-
sion made by the U.S. Food and Drug
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Administration (U.S. FDA) for food color
additives (13). Like the U.S. FDA, the U.S.
EPA will be setting criteria to determine
when in uterotests will be required (14). In
both perinatal and standard carcinogenicity
tests, we found that qualitatively the same
tumors wereproduced, except in the case of
DES (15-17). Quantitatively, we found
that perinatal dosing may or may not result
in a higher tumor incidence than standard
carcinogenic tests. When there is a greater
response, it is difficult to determine ifthe
effect is due to an enhanced sensitivity dur-
ing development or to a greater total dos-
ing, but increases were in the range of20 to
30%. We found also that combined perina-
tal and adult exposure sometimes reduces
the latency period for tumors to develop,
and that enhanced effects were generally
seen forgenotoxins and also for DES.
In addition, there were several other
factors that the U.S. EPA considered in the
development of its proposed policy. First,
DES showed that induction ofdevelop-
mental abnormalities during gestation may
predispose to differential carcinogenic
effects. This leads to the conclusion that
environmental endocrine disruptors may
pose unique susceptibilities for children.
Second, age-related differences in the abil-
ity to metabolize chemicals can alter the
sensitivity to carcinogens. This difference
can go in the direction ofmaking a child
either more susceptible (e.g., cannot
metabolize the carcinogen) or less suscepti-
ble (e.g., cannot form the carcinogenic
metabolite). Third, genetic toxicology test
results do not consistently predict the need
for perinatal testing. However, enhanced
mutations may occur during development
because of significant cell division or
reduced DNA repair with immature repair
systems. Fourth, the immune system is not
fully functional throughout development,
until the third month oflife.
Based on these considerations and
others, the U.S. EPA has proposed a set of
criteria for which chemicals will require in
utero testing, which were reviewed by the
SAP along with reviewers from the U.S.
EPA Science Advisory Board (14). The
factors that the U.S. EPA is proposing to
consider are
* Adverse effects with prenatal/neonatal
dosing are identified that are qualita-
tively or quantitatively different from
those produced in adult and/or sug-
gest potential carcinogenic effects (e.g.,
hyperplasia, dysplasia, inhibition of
apoptosis, inhibition of terminal
differentiation).
* Exposures during prenatal/postnatal
periods are generallyhigh.
* Structure-activity relationship analysis
indicates an association with a chemical
shown to increase sensitivity in perinatal
carcinogenicity tests.
* Margins of exposures between doses
producing adverse effects and anti-
cipated exposure are smaller during
development than during adulthood.
* Pesticide forms adducts with DNA of
fetal tissue.
* Pesticide is transported via the placenta
or breast milk from mother to baby.
* Pesticide is metabolized to the active
carcinogenic moiety during prenatal/
postnatal period.
* Pesticide causes relevant effects due to
estrogenic or other hormonally related
endocrine disruption.
In making decisions on the chemicals
that will require in utero testing, the U.S.
EPA will be using a weight-of-evidence
approach based on a careful evaluation of
factors in combination. We will consider
the nature ofthe toxic response, the ade-
quacy of the exposure assessment for
infants, and the potential dose-response
relationships.
Perinatal carcinogenicity study protocols
will be designed on a chemical-by-chemical
basis. This is because they pose unique
problems, such as determination ofappro-
priate dosage levels. The proposed factors
will be evaluated from time to time for their
adequacy; appropriate modifications will be
made as new information becomes avail-
able. Additional testing could be required at
any time, but an important opportunity
will be registration renewal, which must
occur for all pesticides every 15 years under
FQPA. Clearly, however, more research is
warranted in this area to develop better
methods to predict carcinogenic risks due
to prenatal and neonatal exposures.
Pesticide Tolerance
Reassessment
More immediately, the new food law sets a
10-year schedule for the U.S. EPA to
review about 10,000 existing tolerances for
pesticide residues on food. Within the next
2 years, the U.S. EPA will review the first
third, or about 3300 tolerances, that pose
the worst risks. The first group will include
the organophosphate, carbamate, and
organochlorine classes, as well as chemicals
that may be human carcinogens.
As the U.S. EPA reviews new and exist-
ing pesticides registrations under the new
law, we will find that some-considering
their aggregate exposures and cumulative
effects on children-pose more than a
negligible risk. So we will be canceling
registrations for some existing pesticide
uses and denying requests for new pesti-
cides than may have been allowed under
previous pesticide laws. The important
point here is that over time, pesticides pos-
ing the greatest carcinogenic and other
health riskswill be replaced bysafer conven-
tional pesticides or alternatives, such as inte-
grated pest management, biological controls,
and biotechnology.
The new law's provisions already are
prompting decisions that we probably
would not have made under the previous
law. For example, we denied the renewal of
a tolerance for residues of the fungicide
iprodione on cotton seed, because after
adding the additional risk from drinking
water, the cancer risk was too high (18).
We also denied a request by the state of
California for an emergency exemption to
use iprodione on pistachio nuts due to too
great a cancer risk. Similar actions are
pending. As you can see, our greatest chal-
lenge is to develop the new information
and scientifically valid risk assessment
methods that we need to do the job that
we have been given.
Industrial Chemicals
So we are succeeding in our efforts to
assess and reduce carcinogenic risks posed
by pesticides from children's diets, as well
as from homes, schools, and other unin-
tended pathways. However, we have made
far less progress in defining carcinogenic
and other risks posed by many other
chemicals that our children are exposed to
in their environments.
Our inability to judge the safety ofso
many environmental chemicals was out-
lined by the NRC in 1984 (19), and by the
Office ofTechnology Assessment (OTA)
(20) shortly before it was abolished. Using
the NRC's test methods ofsampling high-
production-volume chemicals, the
Environmental Defense Fund (EDF)
recently came to the same conclusion-
thatwe do not have basic health effects data
for the majority ofnonpesticidal industrial
chemicals produced in the greatest quanti-
ties in the United States (11). Although we
have not yet completed a detailed review of
the EDF report, the results are very close to
the U.S. EPA's statistics for chemicals.
The EDF study indicated that the most
basic toxicity testing results cannot be found
in the public record for 71% oftheapproxi-
mately 3000 high-production-volume
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chemicals in commercial use. The studywas
based on a random sample of 100 chemicals
imported or produced in quantities ofmore
than 1 million pounds per year. In measur-
ingwhether a chemical had qualified as hav-
ing hazard identification available, the study
used the definition ofminimum screening
data required by the international chemical
screening and testing program of the
Organisation for Economic Co-operation
and Development Program (OECD).
The study's sample also indicated that
the majority ofhigh-production-volume
chemicals have been tested only for their
ability to cause mutations and birth defects.
Carcinogenicity tests have not been con-
ducted on 63% ofthe high-production-
volume chemicals sampled.
Of course, many ofthe exposures to
these widely used chemicals can be chronic.
But, while 90% of the high-production-
volume chemicals had been tested for acute
toxicity, less than halfof them had been
tested for any form ofchronic toxicity.
The study contained other dismaying
findings. Forty-seven of the 100 high-
production-volume chemicals sampled were
included in the Toxics Release Inventory
(TRI) and therefore are being emitted into
air, land, and water in quantities ofmore
than 10,000 pounds per year. Toxicity data
was available for less than halfofthe TRI
chemicals. Also, almost 60% ofthe chemi-
cals sampled that met the U.S. EPA criteria
for bioaccumulation and persistence did
not meet basic screening requirements for
health hazard data.
The clear conclusion from the 1984
NRC study, the OTA, and recent EDF
study is not that almost 75% of all the
commercial high-production-volume
chemicals are unsafe, but that we have no
reliable basis on which to determine ifthey
are safe or not. Therefore, we are flying
blind, and do not know where we should
be making efforts to reduce their use and
potential risks, including carcinogenic
risks. We know even less about the remain-
der of the 70,000 chemicals on the U.S.
EPA inventory.
We need to find ways to move ahead
with screening these high-production-
volume chemicals. The U.S. EPA is devel-
oping a toxics agenda-a dear mission and
coherent strategy to systematically identify
and act on the most serious chemical risks.
Our highest priority targets are those chem-
icals to which children are most exposed-
chemicals in their homes, schools, and play
areas. Through the Toxics Agenda we are
seeking to lay the basis for initiatives from
industry, the public, and government
to assess chemicals and make toxicity
data available.
Clearly the 3000 very high-production-
volume (> 1 million lb/year) nonpolymeric
chemicals have the highest priority for
action. Ofthese, only 500 have had testing
under the TSCA-halfofthese since 1992
(21). Clearly more testing is needed. We
would like to see the chemical industry
increase its support ofthe OECD screening
information data sets program, which is
assessing high-volume chemicals on a coop-
erative international basis (22). The purpose
of this effort is to target risks and those
chemicals that require further study. A key
advantage ofthis approach is that its testing
costs are shared with other countries, which
should speed the task. We also would like to
see stronger authority for the U.S. EPA to
require testing, and a more specific agenda
for testing. Testing for endocrine disruptors,
as required in the Safe Drinking Water Act
(23) and the FQPA (8), is agoodbeginning.
This year, the U.S. EPA plans to focus
several initiatives at reducing children's
exposures to toxics and potential carcino-
gens. One is an agencywide effort to target
reductions in all media environmental pro-
grams persistent bioaccumulative toxic
chemicals, such as dioxin, polychlorinated
biphenyls, and mercury, that also may be
carcinogens. We also plan to expand our
consumer labeling initiative (24) beyond
pesticides to labels on household and other
consumer products, such as deaning agents
and latex paint, with the goal ofproviding
more readily understandable information
on hazards, especially to children.
Along the same lines, the U.S. EPA
plans to make protection ofindoor envi-
ronments a higher priority. This effort is
gaining momentum. Almost every program
and regional office is involved in planning
a strategy that will make the most of our
resources and existing legislative authori-
ties. The effort will include protection
from indoor air pollution as well as other
indoor health hazards.
We know that radon is estimated to
account for 7000 to 30,000 lung cancer
deaths annually (25), and that environ-
mental tobacco smoke is estimated to
account for 3000 annual lung cancer
deaths in nonsmokers (26). We know that
some consumer and commercial products
and building materials emit chemicals that
are suspected carcinogens (27). We do not
know how many cases ofchildhood cancers
are caused by these exposures, but we are
focusing our efforts on protecting children
from exposures that pose the highest risks.
On another initiative that I mentioned,
we plan to begin to screen chemicals for
their ability to mimic hormones. We will
be looking at pesticides, which I men-
tioned, and at water contaminants. A fed-
eral advisory committee, the Endocrine
Disruptor Screening and Testing Advisory
Committee, is developing an implemen-
tation plan that is due in August 1998.
Screening is slated to begin in 1999.
These initiatives are promising, and we
are taking major steps to give our children
added protections against cancers from pes-
ticides. But we have a long way to go in
understanding cancer risks posed by indus-
trial chemicals, and therefore, we are far
from being able to effectively regulate their
carcinogenic risks to children.
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